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Resistance of plants to the pathogenic bacteria that infect
them involves elaborate defense and counter-defense systems.
The initial plant defense reaction, known as PAMP-triggered
immunity (PTI), follows from the recognition of one of many
‘pathogen-associated molecular patterns’ (PAMPs), such as
components of the bacterial flagellum or the bacterial
translational machinery (Figure 1) [1]. To counteract PTI,
bacteria inject dozens of ‘effector’ proteins into the plant cell
via a specialized secretion system. These effector proteins
alter the plant cell’s transcriptome and proteome to
reprogram the cell to become susceptible to the pathogen. If
the effector molecules are recognized by the host cell, they
trigger an additional layer of defense known as effector-
triggered immunity (ETI; see Figure 1) [1]. In the past few
years, silencing of plant gene expression via host-encoded
small RNAs has been implicated in both PTI and ETI [2,3].
Work from the laboratory of Olivier Voinnet published
recently in Science (Navarro et al. [4]) sheds further light on
this struggle between pathogen and host by identifying a
mechanism by which the bacterial pathogen can suppress
the RNA-mediated silencing of endogenous gene expression
that helps set up the state of PTI.
The first evidence that small RNAs were involved in plant
defense and bacterial counter-defense came from the
analysis of changes in the plant transcriptome induced by
one of the bacterial effector molecules - AvrRpt2. Recog-
nition of this effector protein by the host cell induces
convergent transcription at a locus in the plant genome such
that the overlapping and complementary transcripts can
anneal to generate a double-stranded (ds) RNA [2]. This
dsRNA is then processed into a type of small RNA known as
natural antisense small interfering RNA (nat-siRNA), which
is typically 21 to 24 nucleotides long. The small RNAs
induced by AvrRpt2 silence protein-coding genes in the
plant genome and their effect is to enhance ETI. Similarly,
recognition of a peptide from bacterial flagellin has been
shown to induce accumulation of another small RNA, the
microRNA (miRNA) miR393, which represses the
production of proteins involved in auxin signaling in the
plant cell, in this case enhancing the first line of defense -
PTI [3].
The recent work from Voinnet’s laboratory [4] provides
further support for the involvement of RNA-mediated
silencing in the PTI defense against bacteria. They show that
loss of miRNA pathways in Arabidopsis thaliana results in
loss of PTI against an Arabidopsis pathogen, Pseudomonas
syringae, and loss of the similar ‘innate’ resistance to plant
pathogenic bacteria that do not normally infect Arabidopsis
(non-host resistance). They go on to uncover distinct effector
proteins - known as silencing suppressors - from P. syringae
that inhibit this RNA-mediated component of PTI. A final
part of their analysis may have relevance to crop plants in
the field, because they show how there can be synergism
between viral and bacterial pathogens due to the ability of
their silencing suppressors to target different stages in the
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To investigate the involvement of small RNAs in disease
resistance, Voinnet and colleagues analyzed the A. thaliana
mutants dcl1 and hen1, which are defective in components of
pathways that produce small RNAs. The wild-type gene
DCL1 encodes the enzyme Dicer, which is responsible for
precursor miRNA processing, and HEN1 encodes an enzyme
that methylates the 2’ hydroxyls of siRNAs and miRNAs to
protect them from degradation [5]. Strong mutant alleles at
either locus cause an almost total absence of miRNA
accumulation, including that of the PAMP-responsive
miR393. In addition, the hen1 mutant displays a dramatic
loss of endogenous siRNAs, including nat-siRNAs. These
mutants were infected with P. syringae pv. tomato strain
DC3000 (Pto DC3000) in which the effector molecule
secretion system had been eliminated. This mutant strain is
recognized by the plant, but cannot inject effector proteins
into the host cell and therefore grows very weakly on a wild-
type plant. On dcl1 or hen1 mutants, however, bacterial growth
was significantly increased, indicating that these mutants are
defective in PAMP perception or signaling. Enhanced
bacterial growth on the miRNA-defective mutant was not
surprising, as these plants cannot produce the PAMP-
responsive miR393, which is known to aid resistance to Pto
DC3000. It is notable, however, that hen1 and dcl1 allow a
similar level of pathogen growth, whereas none of the other
small RNA mutants tested, including the dcl2 dcl3 dcl4
triple mutant, which produces miRNAs but no other small
RNAs, allows pathogen growth. This difference indicates
that miRNAs and not siRNAs are involved in PTI.
Strikingly, when plant pathogenic bacteria that do not
normally infect Arabidopsis are inoculated into dcl1 or hen1
plants, they also exhibit enhanced growth. On a wild-type
host these bacteria trigger PTI, but are unable to overcome it
as they do not produce the appropriate effector proteins [1].
On miRNA-mutant hosts PTI is compromised and so the
pathogens are successful. It will be interesting to discover
whether the effect seen in the miRNA mutants is due to the
loss of many miRNAs or only of miR393, the only miRNA
known until now to affect disease resistance. As we discuss
later, Voinnet and colleagues [4] give evidence that multiple
miRNAs are affected by pathogen infection, but the signifi-
cance of these changes in relation to disease is unknown.
The growth of both the secretion-defective Pto DC3000 and
the ‘non-host’ pathogens on Arabidopsis dcl1 and  hen1
mutants is not as robust as the growth of Pto DC3000 with
an intact secretion system. This perhaps indicates that
miRNAs play a role in host susceptibility as well as in
resistance and that only their cumulative effect can be
observed in mutants. The lack of robust pathogen growth in
miRNA mutants may also be due to the pleiotropic nature of
these mutations. Strong alleles of dcl1 and  hen1 have
morphological phenotypes that may affect pathogen growth
in a way that is unrelated to the defense pathways discussed
here. Comparing the growth of virulent Pto DC3000 on
these mutants would help answer this question.
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The short life cycles of bacteria and the extreme selective
pressure of a pathogenic lifestyle make it likely that bacteria
have evolved means to evade or combat miRNA-mediated
resistance. Just as plant viruses are known to have evolved
multiple suppressors of silencing [6-9], so bacteria may have
evolved bacterial suppressors of silencing. With this hypo-
thesis in mind, Voinnet and colleagues [4] searched through
Pto DC3000 effector molecules for those that affect miRNA
biogenesis, maturation and function (Figure 2).
They found that the effector protein AvrPtoB, when
expressed transiently in Arabidopsis leaves, causes a
decrease in the accumulation of the miR393 precursors
primary miR393a (pri-miR393a) and pri-miR393b. This
effect is likely to be at the transcriptional level, as a miR393
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Multiple lines of plant defenses against bacterial pathogens. Recognition of
pathogen-associated molecular patterns (PAMPs) by the plant cell induces
PAMP-triggered immunity (PTI; green arrow), which involves the
coordinated expression and repression of plant-cell genes to combat
pathogen growth. Bacterial pathogens such as Pseudomonas syringae inject
effector proteins (orange shapes) into the host cell to reprogram the
proteome and transcriptome for susceptibility (orange arrow).
Recognition of effector proteins by host proteins (purple hexagon) induces










Pampspromoter-green fluorescent protein reporter construct is
transcribed at a reduced rate in the presence of AvrPtoB
both before and after induction by a PAMP. This observation
is consistent with a known role for AvrPtoB in suppression
of other PAMP-responsive genes. In addition to miR393,
several other miRNAs are reported to increase upon
infection with secretion-defective Pto DC3000 [10]. Of
these, miR396 at least appears to be transcriptionally
repressed by AvrPtoB. However, it is unlikely that AvrPtoB
functions as a general repressor of miRNA transcription, as
Voinnet and colleagues [4] show that at least some pri-
miRNAs are unaffected by AvrPtoB. Whether this silencing
suppressor is capable of repressing non-PAMP-responsive
pri-miRNAs is unknown.
AvrPto, an effector molecule unrelated to AvrPtoB, also
functions as a suppressor of silencing. When Voinnet and
colleagues [4] transiently expressed AvrPto in wild-type
Arabidopsis they found a decrease in the accumulation of
miR393, miR171 and miR173. Likewise, in stable transgenic
Arabidopsis lines that carry an inducible AvrPto, the authors
found that mature miRNA levels decreased upon induction
without alteration in the transcription rate of pri-miRNAs.
For miR393 at least, accumulation of a partially processed
RNA is detected, supporting the conclusion that AvrPto
interferes with miRNA processing. Voinnet and colleagues
[4] also identify two other bacterial effector proteins, HopH1
and HopN1, that affect mature miRNA accumulation
without reducing pri-miRNA levels, although they cannot
rule out the possibility that these proteins affect miRNA
stability rather than processing.
It will be particularly interesting to know whether these
proteins suppress the processing of all small RNAs, all
http://genomebiology.com/2008/9/10/237 Genome B Bi io ol lo og gy y 2008, Volume 9, Issue 10, Article 237 Mosher and Baulcombe 237.3
Genome B Bi io ol lo og gy y   2008, 9 9: :237
F Fi ig gu ur re e   2 2
Bacterial suppressors of silencing interfere with miRNA-mediated host defense. Bacterial infection is initially perceived by the plant cell through PAMPs,
as in the recognition of flagellin by the plant receptor FLS2 illustrated here. This triggers a signaling cascade that activates transcription of primary-
microRNAs (pri-miRNAs) from the plant genome, which are then processed into mature miRNAs (red line). miRNA is bound by the protein Argonaute1
(light blue) and the miRNA-Argonaute1 complex silences specific mRNAs, enhancing resistance to the pathogen (PTI). The pathogen injects numerous
effector proteins (orange shapes) into the host cell in an attempt to reprogram the cell to become susceptible to the pathogen. Voinnet and colleagues
















BacteriummiRNAs, or only a subset of miRNAs. Voinnet and
colleagues [4] find that HopH1 and HopN1 reduce accumu-
lation of the trans-acting siRNA tas255, hinting that they
may affect a conserved process in small RNA processing;
however, production of this siRNA requires the action of a
miRNA, so the effect of these silencing suppressors may be
specific to a subset of miRNAs. Were these proteins to
broadly inhibit small RNA maturation they would be a
powerful tool for research on small RNAs.
The final step at which bacterial effector proteins might
suppress miRNA-mediated defense is by inhibiting the
action of miRNAs. Bound into Argonaute1, miRNAs can
silence gene expression by cleaving mRNAs or by inhibiting
their translation [5,11]. Voinnet and colleagues [4] find that
the effector protein HopT-1 appears to interfere with both
functions when stably expressed in Arabidopsis. The mRNA
levels of several miRNA targets increase when HopT-1 is
present, as does the protein level of at least one translational
inhibition target. Furthermore, HopT-1 expression interferes
with silencing induced by a transgene, indicating that it may
function widely to inhibit Argonaute1 function. Consistent
with this observation, lines overexpressing HopT-1 are
smaller than wild-type plants, which may indicate pleio-
tropic effects due to general suppression of small RNAs. To
what extent HopT-1 interferes with small RNA function, or
the mechanism by which it suppresses Argonaute1, are yet to
be determined.
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The most exciting implications of the work of Voinnet and
colleagues [4] involve interactions between multiple patho-
gens on a single host. In natural conditions, organisms are
bombarded by many potential microorganisms at one time.
These pathogens may have neutral effects on one another,
but more frequently they are antagonistic or synergistic. In
some cases this may be due to the host’s choice of defense
strategy, as is the case in systemic acquired resistance, when
recognition of a single biotrophic pathogen (a pathogen that
takes nutrients from living tissue) enhances resistance to a
broad range of other pathogens but leaves the host vulner-
able to necrotrophic pathogens (a pathogen that takes
nutrient from dead tissue) [12]. In other instances, pathogen-
pathogen interactions may be more specific.
A role for small RNAs in virus resistance in plants has been
known for some time [13,14]. Double-stranded RNA from
viral replication intermediates or from secondary structures
within the viral transcript is cleaved by host factors into
small RNAs that target further degradation of viral
transcripts and homologous sequences from the host. The
proteins known as viral suppressors of silencing (VSRs) were
discovered soon after, and it is likely that every plant virus
encodes a VSR, with those from different viruses acting at
different points in the RNA-mediated silencing pathway. In
the case of viral resistance, the small virus-derived RNAs are
the initial layer of defense, analogous with PTI, and the viral
suppressor proteins are the counter-defense. VSRs can
inhibit proteins that stabilize siRNA (for example, the VSR
Hc-Pro), target the degradation of proteins that effect gene
silencing (for example, the VSR P0), or bind siRNA duplexes
(for example, the VSR P19) [6-9].
A well characterized example of a synergism that depends on
VSRs is that between potato virus X (PVX) and the potyvirus
potato virus Y (PVY). In this case, expression of the VSR Hc-
Pro from PVY causes hyperaccumulation of PVX [15]. Inter-
estingly, the synergism only occurs in one direction - PVY
accumulates to the same level regardless of the presence of
PVX, even though PVY also carries a VSR. Voinnet and
colleagues [4] further expand our understanding of patho-
gen synergism by showing that infection with turnip mosaic
virus, another potyvirus that encodes the VSR Hc-Pro, elimi-
nates PTI against bacteria and allows ‘non-host’ bacterial
pathogens to grow on Arabidopsis. How widespread this
effect may be is unknown, but it provides insights into the
challenge of protecting crops from pathogens.
Host-pathogen interactions are intricate and well balanced,
as each organism tries to gain advantage in the battle for
survival. As we learn that small RNAs are involved in nearly
all biological processes, it is not surprising to discover that
they are both weapons against pathogens and targets of
pathogen attack. The work of Voinnet and colleagues [4]
highlights the significance of miRNA-mediated resistance
and the lengths to which bacteria have gone to suppress this
resistance. The presence of suppressors of RNA silencing in
both viruses and bacteria allows diverse pathogens to work
together and defeat host defenses, and opens up the
possibility that small RNA defenses and suppressors might
be found in many more host-pathogen interactions.
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